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This Month in the Journal
With this issue, we inaugurate ‘‘Human Genetics ’97,’’ promoter region is lost. Schwemmle et al. suggest that
methylation abolishes expression by interfering with thea collection of invited reviews and editorials that cluster
around a single broad theme. This month’s focus is on interaction of transcriptional activators with the FMR1
promoter.behavioral genetics. We feature an ASHG policy state-
ment on the topic (Sherman et al., p. 1265), as well as
Promoter Duplication of Human mtDNA, by Hao etreviews of recent advances in mood disorders (Reus and
al. (p. 1363)Freimer, p. 1283), childhood psychiatric disorders
(Smalley, p. 1276), and sleep disorders (Mignot, p. Here, Hao et al. report on their cell-culture studies on
a 260-bp duplication that affects the major heavy- and1289). In coming months, this series will feature articles
on gene regulation; the use of large-mammal model sys- light-strand promoters in the mitochondrial genome.
This duplication has been described before, and severaltems to approach human genetics; gene therapy; and
other areas of interest to human geneticists. groups, including these authors, speculated that it might
be a pathological variant. However, working with trans-
Linkage of a High-Bone-Mass Trait, by Johnson et al. mitochondrial cybrids—cloned cells in which the only
(p. 1326) mtDNA is derived from other cells—Hao et al. have
Bone mineralization density (BMD) is a quantitative now examined oxidative phosphorylation and mtDNA
trait that is strongly inﬂuenced by age, sex, and environ- replication in the presence of this duplication. By both
ment. Although twin studies have demonstrated that of these measures, cells in which ú99% of mtDNA car-
BMD is also profoundly affected by heredity, the genetic ries the duplication appear normal. These ﬁndings do
control of BMD is not well understood. Johnson et al. not rule out an effect of the duplication in some special-
examined a healthy young woman who appears to have ized cells, but they strengthen the argument that the
inherited high BMD as an autosomal dominant trait duplication represents a neutral polymorphism.
through her mother’s family. Linkage analysis within
this family suggests that a high-penetrance gene that Molecular Basis of Acute Porphyria, by Puy et al.
(p. 1373)maps within a 30-cM interval on 11q contributes to
high BMD. The mapping of this putative quantitative- Puy et al. explore the beneﬁts of DNA-based diagnosis of
trait locus near a gene for osteoporosis pseudoglioma acute intermittent porphyria (AIP), a heme-biosynthesis
syndrome raises the possibility that the two traits, one defect that arises from deﬁcient expression of porphobil-
with high and the other with low bone density, are al- inogen deaminase (PBD). The established approach of
lelic. See the commentary by Whyte in this issue. assaying erythrocytes may fail for several reasons. For
instance, some alleles affect only nonerythroid cells.Analysis of the FMR1 Promoter, by Schwemmle et al.
Also, many individuals who are apparently at risk on the(p. 1354)
basis of genotype show normal PBD levels and remain
Fragile X syndrome may arise through loss of expression asymptomatic. Puy et al. used denaturing gradient gel
of the FMR1 gene, typically as a consequence of an electrophoresis (DGGE) to study 129 French AIP fami-
expansion in a CGG trinucleotide in the FMR1 pro- lies. They deﬁne mutations, 33 of them novel, in 109 of
moter. Earlier analysis of this promoter used methyla- these families. Of the biochemically diagnosed families,
tion-sensitive restriction enzymes to show that CpG se- only 12 lack an evident mutation in PBD. The authors
quences are hypermethylated in cells of affected argue that the DGGE method is well suited to presymp-
individuals. Schwemmle et al. have now extended this tomatic identiﬁcation of AIP individuals and particu-
observation in several respects. They applied ligation- larly, AIP carriers.
mediated PCR to conﬁrm that, in immortalized ﬁbro-
blasts taken from affected individuals, methylation is Mutations in Duplicated Region of PKD1, by Peral et
essentially complete at all sites examined. However, they al. (p. 1399)
ﬁnd no evidence for such methylation in asymptomatic Mutations in the PKD1 gene frequently lead to renal
people, including transmitting individuals with ex- failure, a consequence of polycystic kidney disease. Nu-
panded CGG repeats. The authors have also used in vivo merous mutations at the 3 end of the gene have been
footprinting to show that, accompanying this increase characterized in PKD1 families, but the 5 end of the
in methylation, binding of factors to four sites in the gene, which resides in a tandemly repeated portion of
16p, has not been amenable to mutation analysis. Peral
et al. describe a method, based on reverse-transcriptase– 1997 by The American Society of Human Genetics. All rights reserved.
0002-9297/97/6006-0001$02.00 PCR (RT-PCR), by which 12 of the 32 previously un-
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characterized 5 exons can be ampliﬁed without contam- This syndrome presents with inverted facial musculature
ination from upstream sequences. The initial ampliﬁca- and a variety of urinary-tract abnormalities that predis-
tion product is then characterized at the sequence level pose to infection and, hence, to kidney disease. Working
or by the protein-truncation test. This approach yielded with both consanguineous and nonconsanguineous fam-
11 mutations among 11 familial or sporadic cases of ilies that exhibit this autosomal recessive disorder, Wang
PKD. Despite this success, it clearly represents only a et al. have performed whole-genome scanning to ﬁnd
partial solution to the problem, because it can only be markers that are homozygous speciﬁcally in the patient
applied to alleles that are expressed sufﬁciently to be set. At the same time, they pooled genomic DNA from
detected by RT-PCR, and because the 20 5-most exons patients and from obligate carriers and analyzed these
are excluded from this analysis. for quantitative differences in allele distribution that
suggest linkage. After examining a total of only 24 sam-SMNT and SMNC Gene Copy Number, by McAndrew
ples, they report that the homozygosity and the poolinget al. (p. 1411)
methods both indicate linkage to 10q, probably withinSpinal muscle atrophy (SMA) is another disease in which
a 1-cM region.molecular diagnosis is complicated by sequence duplica-
tion in the genome. Two highly homologous genes,
Complementation of NBS by Chromosome 8q, bySMNC and SMNT, reside on 5q; mutations in SMNT are
speciﬁcally associated with SMA. Quantitative competi- Matsuura et al. (p. 1487)
tive PCR has been employed to identify SMNT deletions, The Nijmegan breakage syndrome (NBS) presents with
but previous studies have measured the ratio of SMNC a complex of developmental abnormalities and a cellular
and SMNT copies. As McAndrew and colleagues now phenotype of radiosensitivity and cell-cycle misregula-
show, however, this ratio may be misleading, because tion, a phenotype reminiscent of severe combined immu-
the number of copies of SMNC varies among SMA indi- nodeﬁciency (SCID). Matsuura and co-workers have re-
viduals. Instead, this group has developed a competitive visited some earlier cell-fusion studies that seemed to
PCR method that normalizes copy number of SMNT to indicate that there were at least two NBS complementa-
that of an unlinked and stable genomic fragment. They tion groups. Using isolated chromosomes and chromo-
show here how they used this method to detect a twofold somal fragments delivered in minicells, these authors
loss of SMNT signal in a compound heterozygote with show that a region of 8q complements NBS in all cells,
a deletion affecting one copy and with a point mutation suggesting that the defect is homogeneous. The gene
in the remaining copy of the gene.
associated with human SCID maps to an 8q region dis-
Mapping of the Urofacial Syndrome Gene, by Wang tinct from this NBS-complementing locus.
et al. (p. 1461)
JOHN ASHKENASWang and co-workers have applied two powerful link-
age strategies to map the gene for urofacial syndrome. Editorial Fellow
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